Delivery Order SPE2DR25D2005-SPE2DR26FF1F4
- Not listed
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,632.60 by the Defense Logistics Agency on January 30, 2026, for the supply of Trulicity 1.5 mg/0.5 ml pen injections. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 2, 2026, and was competitively awarded without set-aside designation. This delivery order operates under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was awarded a delivery order by the Defense Logistics Agency (DLA) on January 23, 2026, for Trulicity 3 mg/0.5 mL pens valued at $1,582.40. The contract represents a firm fixed-price delivery order with an ultimate completion date of January 26, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, consistent with...
- On January 14, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,944.36 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors. This firm fixed-price contract, with an ultimate completion date of January 15, 2026, represents a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999.00 and running through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,702.70 by the Defense Logistics Agency (DLA) on June 2, 2025, with an ultimate completion date of June 3, 2025. The delivery order is for Trulicity 1.5 mg/0.5 ml pen injectables and was issued under a firm fixed-price, non-set-aside competitive contract. This child delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 23, 2025, for the supply of Trulicity 3 mg/0.5 ml pens. The contract carries a ceiling value of $5,723.04 and features firm fixed-price pricing with an ultimate completion date of June 24, 2025. This is an unset-aside, competitively awarded delivery order representing a single-line item pharmaceutical procurement. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for Trulicity 1.5 mg/0.5 ml pen (0.5 ml) on September 12, 2025. The contract is valued at $1,201.20 under firm fixed-price terms with an ultimate completion date of September 15, 2025. This delivery order is not set-aside and represents a competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trulicity 3 mg/0.5 ml pen injections, valued at $1,641.36, with an ultimate completion date of July 22, 2025. The contract was competitively awarded on July 21, 2025, using firm fixed pricing with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a single pharmaceutical procurement under...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., has been awarded a delivery order valued at $5,607.07 by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pen injections. The contract, which is not set-aside and employs firm fixed-price terms, was awarded on January 6, 2026, with an ultimate completion date of January 7, 2026. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 2, 2026, by the Defense Logistics Agency for the supply of Trulicity 0.75 mg/0.5 ml pens valued at $1,424.16. The award represents a competitive, non-set-aside contract with firm fixed pricing and is scheduled for completion by January 5, 2026. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FF1F4Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on January 21, 2026, for Trulicity 1.5 mg/0.5 ml pen injections with a ceiling value of $2,842.99 and an ultimate completion date of January 22, 2026. This award utilizes a firm fixed-price contract structure and was competitively awarded with no set-aside designation. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide. The parent company of the awardee is Cencora, Inc., which operates under the doing-business-as name AmerisourceBergen and holds a substantial Indefinite Delivery Contract with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2031. This delivery order for Trulicity, a diabetes medication, is representative of AmerisourceBergen's extensive portfolio of pharmaceutical products delivered to federal medical systems, including specialty medications, vaccines, and medical devices across multiple therapeutic domains that support military treatment facilities and other government healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 1/20/26 |